than our mature cigarette business.
74
Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements and whether to invest in or remain invested in our securities. In connection with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, we are identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by us; any such statement is qualified by reference to the following cautionary statements. We elaborate on these and other risks we face throughout this document, particularly in Item 1A.
Risk Factors
and
Business Environment
of this section. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider the following to be a complete discussion of all potential risks or uncertainties. We do not undertake to update any forward-looking statement that we may make from time to time, except in the normal course of our public disclosure obligations.
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk.
The information called for by this Item is included in Item 7,
Market Risk
.
75
Item 8.
Financial Statements and Supplementary Data.
Consolidated Statements of Earnings
(in millions of dollars, except per share data)
(1)
Includes net revenues from related parties of $
3,876
million, $
3,553
million and $
3,658
million for the years ended December 31, 2024, 2023 and 2022, respectively
(2)
Net revenues are shown net of excise tax on products. For the years ended December 31, 2024, 2023 and 2022, excise tax on products was $
51,563
million, $
49,404
million and $
48,958
million, respectively
See notes to consolidated financial statements.
76
Consolidated Statements of Comprehensive Earnings
(in millions of dollars)
See notes to consolidated financial statements.
77
Consolidated Balance Sheets
(in millions of dollars, except share data)
(1)
Includes trade receivables from related parties of $
691
million and $
710
million as of December 31, 2024, and 2023, respectively.  For further details, see Note 6.
Related Parties - Equity Investments and Other.
See notes to consolidated financial statements.
78
See notes to consolidated financial statements.
79
Consolidated Statements of Cash Flows
(in millions of dollars)
See notes to consolidated financial statements.
80
(1)
The amounts for cash, cash equivalents and restricted cash shown above include restricted cash of $
38
million, $
86
million and $
10
million as of December 31, 2024, 2023 and 2022, respectively, which were included in other current assets in the consolidated